# Danaher Corp: overview

DHR · NYSE · CIK 313616 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dhr.md) · [Financials](/companies/dhr/financials.md) · [Filings](/companies/dhr/filings.md) · [Insiders](/companies/dhr/insiders.md)

Latest reported revenue: [$6.55bn](/filings/0000313616-26-000199.md) for Q3 FY2026, three months to 2026-09-25, from the 10-Q filed Oct 21, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000313616-26-000199).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) | Q3 FY2026 (2026-09-25) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,538 d](/filings/0000313616-26-000062.md) | [5,741](/filings/0000313616-26-000107.md) | [5,936](/filings/0000313616-26-000161.md) | [6,053](/filings/0000313616-26-000199.md) | [6,838 d](/filings/0000313616-26-000062.md) | [5,951](/filings/0000313616-26-000107.md) | [6,265](/filings/0000313616-26-000161.md) | [6,554](/filings/0000313616-26-000199.md) |
| Gross margin | % | [59.5% d](/filings/0000313616-26-000062.md) | [61.2%](/filings/0000313616-26-000107.md) | [59.3%](/filings/0000313616-26-000161.md) | [58.2%](/filings/0000313616-26-000199.md) | [58.0% d](/filings/0000313616-26-000062.md) | [60.3%](/filings/0000313616-26-000107.md) | [57.6%](/filings/0000313616-26-000161.md) | [58.5%](/filings/0000313616-26-000199.md) |
| Operating margin | % | [21.8% d](/filings/0000313616-26-000062.md) | [22.2%](/filings/0000313616-26-000107.md) | [12.8%](/filings/0000313616-26-000161.md) | [19.1%](/filings/0000313616-26-000199.md) | [22.0% d](/filings/0000313616-26-000062.md) | [22.6%](/filings/0000313616-26-000107.md) | [18.0%](/filings/0000313616-26-000161.md) | [19.0%](/filings/0000313616-26-000199.md) |
| Net margin | % | [16.6% d](/filings/0000313616-26-000062.md) | [16.6%](/filings/0000313616-26-000107.md) | [9.3%](/filings/0000313616-26-000161.md) | [15.0%](/filings/0000313616-26-000199.md) | [17.5% d](/filings/0000313616-26-000062.md) | [17.3%](/filings/0000313616-26-000107.md) | [13.9%](/filings/0000313616-26-000161.md) | [18.8%](/filings/0000313616-26-000199.md) |
| Diluted EPS | $ per share | not reported | [1.32](/filings/0000313616-26-000107.md) | [0.77](/filings/0000313616-26-000161.md) | [1.27](/filings/0000313616-26-000199.md) | not reported | [1.45](/filings/0000313616-26-000107.md) | [1.23](/filings/0000313616-26-000161.md) | [1.75](/filings/0000313616-26-000199.md) |
| Free cash flow | $m | [1,503 d](/filings/0000313616-26-000062.md) | [1,054](/filings/0000313616-26-000107.md) | [1,090 d](/filings/0000313616-26-000161.md) | [1,370 d](/filings/0000313616-26-000199.md) | [1,746 d](/filings/0000313616-26-000062.md) | [1,085](/filings/0000313616-26-000107.md) | [1,265 d](/filings/0000313616-26-000161.md) | [1,631 d](/filings/0000313616-26-000199.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [24.8](/filings/0000313616-24-000052.md) | [26.6](/filings/0000313616-25-000043.md) | [23.9](/filings/0000313616-26-000062.md) | [23.9](/filings/0000313616-26-000062.md) | [24.6](/filings/0000313616-26-000062.md) |
| Gross margin | % | [61.4%](/filings/0000313616-24-000052.md) | [60.8%](/filings/0000313616-25-000043.md) | [58.7%](/filings/0000313616-26-000062.md) | [59.5%](/filings/0000313616-26-000062.md) | [59.1%](/filings/0000313616-26-000062.md) |
| Operating margin | % | [25.7%](/filings/0000313616-24-000052.md) | [28.3%](/filings/0000313616-25-000043.md) | [21.8%](/filings/0000313616-26-000062.md) | [20.4%](/filings/0000313616-26-000062.md) | [19.1%](/filings/0000313616-26-000062.md) |
| Net margin | % | [25.9%](/filings/0000313616-24-000052.md) | [27.1%](/filings/0000313616-25-000043.md) | [19.9%](/filings/0000313616-26-000062.md) | [16.3%](/filings/0000313616-26-000062.md) | [14.7%](/filings/0000313616-26-000062.md) |
| Diluted EPS | $ per share | [8.61](/filings/0000313616-24-000052.md) | [9.66](/filings/0000313616-25-000043.md) | [6.38](/filings/0000313616-26-000062.md) | [5.29](/filings/0000313616-26-000062.md) | [5.05](/filings/0000313616-26-000062.md) |
| Free cash flow | $bn | [7.1](/filings/0000313616-24-000052.md) | [7.4](/filings/0000313616-25-000043.md) | [5.8](/filings/0000313616-26-000062.md) | [5.3](/filings/0000313616-26-000062.md) | [5.3](/filings/0000313616-26-000062.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dhr/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-28 | [McGrew Matthew](/insiders/1754423.md) | Executive Vice President, Officer | Sale (S) | 15,603 | $236.0939 | $3.7m | [Form 4](/filings/0000313616-26-000204.md) |
| 2026-10-28 | [McGrew Matthew](/insiders/1754423.md) | Executive Vice President, Officer | Sale (S) | 14,151 | $235.3523 | $3.3m | [Form 4](/filings/0000313616-26-000204.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $10.49bn | 55,084,630 |  | Added +3,444,011 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $7.88bn | 41,377,076 |  | Added +249,266 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $5.63bn | 29,540,895 |  | Added +7,006,566 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $5.43bn | 28,456,019 |  | Added +561,838 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $3.11bn | 16,316,834 |  | Added +1,542,310 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $2.95bn | 15,504,420 |  | Added +1,489,707 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.71bn | 14,280,335 |  | Added +134,577 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.71bn | 14,205,213 |  | Added +250,508 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $2.35bn | 12,185,400 |  | Reduced −4,732,249 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.16bn | 11,348,958 |  | Added +139,718 |

## Recent filings

[All 2,784 filings](/companies/dhr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 17:43 ET | [8-K](/filings/0000313616-26-000201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313616-26-000201 |
| 2026-10-21 | 17:40 ET | [10-Q](/filings/0000313616-26-000199.md) | Quarterly report, period 2026-09-25 | 0000313616-26-000199 |
| 2026-10-13 | 08:53 ET | [8-K](/filings/0000313616-26-000193.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000313616-26-000193 |
| 2026-08-03 | 16:27 ET | [8-K](/filings/0001193125-26-330652.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-330652 |
| 2026-07-21 | 17:55 ET | [8-K](/filings/0000313616-26-000163.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313616-26-000163 |
| 2026-07-21 | 17:48 ET | [10-Q](/filings/0000313616-26-000161.md) | Quarterly report, period 2026-06-26 | 0000313616-26-000161 |
| 2026-06-03 | 16:30 ET | [8-K](/filings/0001193125-26-255555.md) | 2.03 New direct financial obligation; 8.01 Other events | 0001193125-26-255555 |
| 2026-05-07 | 16:36 ET | [8-K](/filings/0000313616-26-000127.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000313616-26-000127 |
| 2026-04-29 | 16:14 ET | [8-K](/filings/0001193125-26-191608.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-191608 |
| 2026-04-21 | 17:44 ET | [8-K](/filings/0000313616-26-000109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313616-26-000109 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000313616-26-000062.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 313616
- Tickers: DHR
- Exchange: NYSE
- SIC code: 3823 Industrial Instruments For Measurement, Display, and Control
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.